Jun. 1 at 12:07 AM
Don't sleep on
$CERS and their expanding footprint! They recently signed a massive four-year supply agreement with the French Blood Establishment (EFS) to continue the nationwide use of their INTERCEPT Blood System. With positive adjusted EBITDA for the eighth consecutive quarter, this blood safety powerhouse is fundamentally locked in. 💉💰
The technical setup perfectly aligns with this massive fundamental strength. ⚡️ We are seeing a powerful momentum push as price builds a rock-solid floor above the heavy accumulation zone. The sellers are exhausted, and smart money is aggressively defending this higher-low structure! 🧠💸
🐂 Bulls: Must crack and establish firm support above
$2.88 to confirm the breakout and let the winners run! 🎯
🐻 Bears: A hard rejection that drags us back under the
$2.34 floor kills the near-term momentum instantly. 🧱
